US20050115885A1 - Filtering device with associated sealing design and method - Google Patents
Filtering device with associated sealing design and method Download PDFInfo
- Publication number
- US20050115885A1 US20050115885A1 US10/982,451 US98245104A US2005115885A1 US 20050115885 A1 US20050115885 A1 US 20050115885A1 US 98245104 A US98245104 A US 98245104A US 2005115885 A1 US2005115885 A1 US 2005115885A1
- Authority
- US
- United States
- Prior art keywords
- ring
- filter device
- annular
- housing
- annular anchor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000013461 design Methods 0.000 title abstract description 19
- 238000007789 sealing Methods 0.000 title abstract description 7
- 238000000034 method Methods 0.000 title description 31
- 238000001914 filtration Methods 0.000 title description 5
- 238000004382 potting Methods 0.000 claims abstract description 29
- 239000000463 material Substances 0.000 claims abstract description 25
- 239000012530 fluid Substances 0.000 claims abstract description 20
- 238000004381 surface treatment Methods 0.000 claims abstract description 12
- 229920001410 Microfiber Polymers 0.000 claims description 33
- 239000003658 microfiber Substances 0.000 claims description 33
- 238000003466 welding Methods 0.000 claims description 21
- 230000037361 pathway Effects 0.000 claims description 8
- 230000032798 delamination Effects 0.000 abstract description 14
- 150000001875 compounds Chemical class 0.000 abstract description 3
- 230000002209 hydrophobic effect Effects 0.000 abstract description 2
- 239000008280 blood Substances 0.000 description 37
- 210000004369 blood Anatomy 0.000 description 37
- 230000008569 process Effects 0.000 description 19
- POFVJRKJJBFPII-UHFFFAOYSA-N N-cyclopentyl-5-[2-[[5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl]amino]-5-fluoropyrimidin-4-yl]-4-methyl-1,3-thiazol-2-amine Chemical compound C1(CCCC1)NC=1SC(=C(N=1)C)C1=NC(=NC=C1F)NC1=NC=C(C=C1)CN1CCN(CC1)CC POFVJRKJJBFPII-UHFFFAOYSA-N 0.000 description 12
- 229920002635 polyurethane Polymers 0.000 description 11
- 239000004814 polyurethane Substances 0.000 description 11
- -1 polypropylene Polymers 0.000 description 10
- 239000004743 Polypropylene Substances 0.000 description 9
- 208000028659 discharge Diseases 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 229920001155 polypropylene Polymers 0.000 description 9
- 238000001631 haemodialysis Methods 0.000 description 7
- 230000000322 hemodialysis Effects 0.000 description 7
- 238000005304 joining Methods 0.000 description 7
- 238000003851 corona treatment Methods 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- 108700012359 toxins Proteins 0.000 description 4
- 239000013626 chemical specie Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 239000000385 dialysis solution Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- 238000004026 adhesive bonding Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 229920005629 polypropylene homopolymer Polymers 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000010504 bond cleavage reaction Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000000976 ink Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000002831 pharmacologic agent Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D63/00—Apparatus in general for separation processes using semi-permeable membranes
- B01D63/02—Hollow fibre modules
- B01D63/031—Two or more types of hollow fibres within one bundle or within one potting or tube-sheet
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D63/00—Apparatus in general for separation processes using semi-permeable membranes
- B01D63/02—Hollow fibre modules
- B01D63/021—Manufacturing thereof
- B01D63/022—Encapsulating hollow fibres
- B01D63/0222—Encapsulating hollow fibres using centrifugal forces
Definitions
- This invention relates to the field of filtering devices, and more particularly, to a hollow fiber type filter device having a single use or disposable design together with a method for using and manufacturing the same.
- FIG. 1 shows an overall side view of an embodiment of the filter device of the present invention.
- FIG. 2 shows an exploded isometric view of the filter device of FIG. 1 in an embodiment of the present invention.
- FIGS. 3A-3D show various views of the ring of FIGS. 1 and 2 of an embodiment of the filter device of the present invention.
- FIG. 4 shows a cross-section view of a portion of the filter device of FIG. 1 in an embodiment of the present invention.
- FIG. 1 shows an overall side view
- FIG. 2 shows an exploded isometric view of an embodiment of the filter device of the present invention.
- Filter Device 100 in this embodiment of the invention is a dialyzer used for hemodialysis.
- the filter device of the present invention could also be used for filtering other types of fluids besides blood, including, but not limited to water, sewage, or other types of chemical separation.
- Filter Device 100 is a dialyzer utilized by patients with kidney disease who suffer from the adverse effects of toxin build-up in their blood.
- Dialysis is a process which employs an artificial kidney to remove those toxins.
- a dialyzer In hemodialysis a dialyzer is used which contains a semipermeable membrane dividing the dialyzer into two compartments. Blood is pumped through one compartment and a dialysate solution through the second.
- blood impurities such as urea and creatinine diffuse through the semipermeable membrane into the dialysis solution by diffusion, convection, and absorption.
- the electrolyte concentration of the dialysis fluid is set so as to maintain electrolytic balance within the patient.
- Dialyzers are known in a variety of configurations.
- the basic concept is to maximize the surface area of the membrane dividing the blood side from the dialysate side, so that the pressure gradient diffusing toxins from the blood side into the dialysate side and diffusing nutrients or pharmacological agents from the dialysate side into the blood side can operate over a wide area.
- Filter Device 100 has a large number of Microfibers 104 (not shown in FIG. 2 ) encased in a Housing 102 , which is a hollow cylinder open at both ends.
- Housing 102 may be open only at one end, and Microfibers 104 are looped in a U-shape in Housing 102 such that both open ends of each microfiber are located at the one open end of Housing 102 (not shown).
- thousands of the hollow semipermeable Microfibers 104 carry blood in a pathway through one set of open ends of each Microfiber 104 , through the interior of each Microfiber 104 , and exiting out of the other open end of each Microfiber 104 .
- the hollow semipermeable Microfibers 104 carry blood in a pathway that enters from one end through a first Blood Inlet/Outlet Port 118 to the opposite end and out through a second Blood Inlet/Outlet Port 118 so that blood flows through the interior of each Microfiber 104 in a first direction.
- Dialysate Inlet/Outlet Ports 110 are also present on opposite ends of Housing 102 .
- a first Dialysate Inlet/Outlet Port 110 carries dialysate in a pathway into Housing 102 , the dialysate flows through Housing 102 in a countercurrent direction to the blood flow and in the space between each Microfiber 104 , and a second Dialysate Inlet/Outlet Port 110 carries the dialysate out of Housing 102 .
- the material exchange thus takes place across the semipermeable membrane that is the walls of each Microfiber 104 .
- Label 114 is preprinted and applied after assembly.
- a Cap 112 screws into each Blood Inlet/Outlet Port 118 after sterilization, and is utilized to ensure an uncontaminated fluid pathway and is typically not removed until the technician is ready to connect the blood lines.
- Filter Device 100 produces a high surface area for material exchange in a relatively low volume device.
- a Filter Device 100 having a 6.3 cm cylindrical diameter and a 25.4 cm length can easily accommodate a bundle of about 12,000 to 13,000 Microfibers 104 . If each Microfiber 104 has a 0.60 cm circumference and is 24 cm long, the total surface area of all 12,000-13,000 Microfibers 104 is approximately 180 cm 2 .
- the manufacture of Filter Device 100 begins by joining Rings 108 into each end of Housing 102 . Each Ring 108 is then joined to Housing 102 . Many different joining techniques may be employed including, but not limited to, spin (friction) welding, laser welding, ultrasonic welding, high frequency welding, gluing, adhesive bonding, solvent bonding, screwing with threads, snap fitting, or any other suitable plastic joining technique. In this embodiment of the invention, spin welding is utilized. A plurality of Nubs 120 spaced apart on the outer surface of Ring 108 constitute the spin welding drive features to assist in the spin welding process. Next, open-ended Housing 102 is filled with a bundle of Microfibers 104 which extend in the longitudinal direction throughout the length of Housing 102 and extending a short distance beyond each end.
- a Potting Cap 202 ( FIG. 2 ) is attached to each Ring 108 to close off each end of Housing 102 .
- Housing 102 is then positioned in a centrifuge to allow rotation about an axis perpendicular to the central longitudinal axis, wherein the axis of rotation extends through the midpoint of Housing 102 .
- Potting Compound 116 is then injected into Dialysate Inlet/Outlet Ports 110 on each end of Housing 102 , is spun in a centrifuge, and the fibers are effectively potted in the dialyzer.
- each end of Housing 102 may be separately spin welded and injected in a two step process.
- polyurethane is used for Potting Compound 116 .
- Epoxy or any other suitable compound may also be used as a potting material. The centrifugal force produced by the rotation in the centrifuge forces Potting Compound 116 to each end, where it sets and hardens.
- Housing 102 is then removed from the centrifuge, and each Potting Cap 202 is removed from each end to expose the hardened Potting Compound 116 encasing the ends of each Microfiber 104 .
- Potting Compound 116 and the encased Microfibers 104 at each end are then cut through in a plane perpendicular to the central longitudinal axis of Housing 102 , and the Microfibers 104 longitudinal axes, to expose the interior channels of each Microfiber 104 .
- each Microfiber 104 are open for blood flow through the interior channels of each Microfiber 104 extending through Housing 102 , but the rest of the space surrounding each Microfiber 104 at both ends of Housing 102 is filled with polyurethane, creating a seal between the blood and dialysate.
- a Flange Cap 106 is attached to each Ring 108 and spin welded together, permanently adhering it to Filter Device 100 .
- This design eliminates an O-ring typically used to assist in the sealing of the blood compartment of a dialyzer.
- Dialysate Inlet/Outlet Port 110 in the walls of Housing 102 which are toward but not at the very ends, remain open for dialysate flow there through.
- a dialysate line is connected to one Dialysate Inlet/Outlet Port 110 and a dialysate return line is connected to the other Dialysate Inlet/Outlet Port 110 .
- the dialysate thus flows through the interior of Housing 102 in the space surrounding the Microfibers 104 in one direction.
- the blood is thus separated from the dialysate by the semipermeable membranes of the microfiber walls, which allow the transfer of liquids, toxins, and nutrients by solute diffusion and pressure gradients.
- dialyzers are reused. After use in a hemodialysis session for a patient, the dialyzer is cleaned and sterilized for subsequent use by the same patient for a next hemodialysis session.
- the cleansing, sterilizing, storing, and cataloging of each dialyzer to ensure safe use by the same patient is an expensive and laborious task, and fraught with risk should the dialyzer not effectively have had all of the sterilizing chemicals removed from the dialyzer and the patient be exposed to the sterilizing agent itself. Additionally, if the sterilization process was not able to effectively sterilize the dialyzer, the patient may be subjected to a “non’ biocompatible medical device. Further logistic risk remain in the case the dialyzers get mixed up and the wrong dialyzer is used with the wrong patient.
- Filter Device 100 of the present invention has solved the high cost problem associated with the current manufacture of disposable dialyzers, but yet maintain the performance and medical requirements necessary for successful hemodialysis.
- any dialyzer inherently has at least two sealing regions in its respective design.
- the blood and dialysate compartments must be sealed from each other to ensure that a blood leak does not occur.
- the second seal consists of sealing either the blood or dialysate compartment from the exterior of the dialyzer.
- polyurethane is used as a potting material to seal to the housing to ensure that the blood and dialysate compartments are sealed from each other.
- An O-ring is typically used to separate the blood from the exterior of the dialyzer.
- the seals in a dialyzer must not only maintain their integrity through a specified shelf life duration and during the dialysis treatment process, but must also maintain their integrity during the manufacturing process.
- the Filter Device 100 of the present invention utilizes molded parts, including Housing 102 and Flange Caps 106 , made with a polypropylene homopolymer that possess comparable general characteristics to the polycarbonate used in the molded components of the Fresenius Hemoflow series of dialyzers, but is considerably less expensive.
- the choice of materials for the dialyzer are heavily dependent upon the manufacturing processes employed.
- the optical property of the polypropylene homopolymer is significantly more “hazy” compared to polycarbonate, the blood and dialysate compartments are still readily visible to technicians.
- Polyurethane in one embodiment of the invention is used as Potting Compound 116 for Filter Device 100 .
- a separate Ring 108 molded from polypropylene is utilized.
- One Ring 108 is spin welded into each end of Housing 102 .
- Flange Caps 106 are then spin welded onto Rings 108 after Filter Device 100 has been potted and cut.
- Other joining techniques as listed above, including laser welding, may be used instead of spin welding.
- spin welding is based on a very simple concept and the process generally can be performed faster, less expensively, and with much less continuous maintenance and re-alignment as compared to laser welding.
- the weld joint designs utilized in Filter Device 100 are very robust and conducive to the rigors of large scale manufacturing.
- each Ring 108 becomes encased in Potting Compound 116 .
- the potting caps are removed, the ends are cut, and Flange Caps 106 are spin weld onto Rings 108 .
- the spin welded region constitutes the second seal region, which seals the blood compartment from the outside of Filter Device 100 (a seal which has typically utilized an O-ring).
- Filter Device 100 is then conditioned during a low flux conditioning process, and then sterilized. Sterilization may be accomplished in a variety of ways, including ethylene oxide (EtO), steam, or radiation sterilization.
- a disadvantage of polypropylene is that its hydrophobic property has a tendency to delaminate from the hydrophilic polyurethane potting material due to the chemistry of surface adhesion between the two materials, resulting in leaks between the blood and dialysate compartments.
- a two-pronged approach has been taken to solve this delamination problem associated with the use of polypropylene. The first involves building a detailed geometry into the design of Ring 108 to minimize delamination or propagation of the delamination through the creation of physical stops, discussed more fully in relation to FIGS. 3A-3D . The second involves the modification of the surface characteristics of the polypropylene to increase adhesion between it and the polyurethane, also discussed more fully in relation to FIGS. 3A-3D .
- FIGS. 3A-3D show various views of an embodiment of the ring of FIGS. 1 and 2 in an embodiment of the single use dialyzer of the present invention.
- FIG. 3A shows a front view of Ring 108 .
- FIG. 3B shows a side view of Ring 108 .
- FIG. 3C shows an isometric cross-sectional view of a portion of Ring 108 as seen along lines B-B of FIG. 3A .
- FIG. 3D shows a cross-sectional view of Ring 108 as seen along line A-A of FIG. 3A .
- Ring 108 is shaped to coincide with Housing 102 and Flange Caps 106 that each Ring 108 is mated with.
- Housing 102 , Flange Caps 106 , and Rings 108 are circular, but other shapes may also be utilized.
- Ring 108 has Annular Tongue 316 which fits into an annular groove in Housing 102 formed by Annular Inner Lip 410 and Annular Outer Lip 412 in an interference based snap fit fashion in one embodiment of the invention (see FIG. 4 ).
- Ring 108 also has Annular Outer Rim 312 and Annular Inner Rim 314 which form an annular groove which is designed to receive Flange Cap 106 in an interference based snap fit (see FIG. 4 ). Potting Cap 202 used in the manufacturing process ( FIG. 2 ) is also designed to fit into this annular groove.
- Ring 108 Several methods are available to treat the surface of Ring 108 to modify its surface energy to increase adhesion between it and the polyurethane, including plasma, corona discharge, and flame treatments. By increasing the ability of the surface of Ring 108 to adhere to the polyurethane, Ring 108 has been shown to be effective in eliminating potential issues regarding delamination. A delamination could potentially allow the two fluid pathways to mix outside of the filtering microfibers.
- the detailed geometry of the design of Ring 108 increases the surface area treatable through surface treatment, enhancing the effects of modifying the surface energy of Ring 108 .
- a typical surface treatment process which allows for the most practical integration into a clean room automated assembly process is the “corona discharge” surface treatment technique.
- This treatment method is currently utilized in industry to increase the adhesion of inks, coatings, and adhesives to polyolefins, such as polypropylene.
- the corona discharge consists of a high voltage electrical discharge that is created between two electrodes across a specified distance. This discharge ionizes the gases present between the electrodes and creates unstable chemical species (mainly free radicals), which possess sufficient energy to initiate bond cleavage at the polymer surface.
- a small fan is situated just above the corona discharge heads and blows the reactive chemical species onto the polymeric surface of the part being treated, Ring 108 , as shown by arrows 308 in FIG. 3D .
- Ring 108 is especially well suited to accommodate the corona discharge treatment process, presenting a large surface area due to its geometric design.
- the corona discharge treatment process is based on the surface being treated to be directly exposed to the electrical discharge, and sections of the surface that are not directly in the “line of sight” of the discharge do not receive as effective treatment.
- Ring 108 is designed to ensure that the polyurethane interface regions of the ring receive optimal amounts of the surface treatment, while also forcing any delamination that may occur to follow a very difficult pathway.
- Annular Rounded Ridges 318 on the upper and lower surfaces of Annular Anchor 306 have relatively sharp transitions between them to ensure that optimal amounts of “treatable” area of Ring 108 are exposed to the corona discharge treatment process.
- delamination is forced to essentially “start” again and again after being initiated anywhere along the Ring 108 /Potting Compound 116 interface as shown in a close up cross-section of Ring 108 , Housing 102 , and Flange Cap 106 shown in FIG. 4 .
- the effects of the corona discharge treatment may also be somewhat distributed onto Annular Rounded Ridges 318 in the lower surface of Annular Anchor 306 as the unreacted unstable chemical species will be blown into the center of Ring 108 and react with the lower surface of Ring 108 , which also is embedded in Potting Compound 116 .
- the thickness of Annular Anchor 306 tends to decrease or taper inwardly from Annular Outer Rim 312 , as opposed to increasing or expanding inwardly, which aids in this surface treatment process.
- Covalent bonds are produced on the surface of the polymer as the surface is oxidized during the treatment process.
- This oxidative coating on the polypropylene surface allows the hydrophilic polyurethane to effectively bond to the modified polypropylene. Because the oxidative coating on the polypropylene has the ability to interact with the oxygen present in the air, and simply the dynamic nature of polymers, the stability of the corona discharge treatment is limited to a specified amount of time. However, once potted, the modified surface of Ring 108 is permanent and does not degrade over time.
- Ring 108 serves as a mechanical lock and is located at an interior portion of Ring 108 and is completely embedded in Potting Compound 116 . This portion of Ring 108 forces delamination to completely circumvent around and through the Annular Rounded Ridges 318 to create an actual delamination between the blood and dialysate compartments of Filter Device 100 as shown in FIG. 4 .
- Ring 108 Another feature of Ring 108 are Radial Channels 302 .
- Radial Channels 302 are periodically notched perpendicular to Annular Rounded Ridges 318 of the upper surface of Annular Anchor 306 of Ring 108 , which allows the air to escape and not become trapped during “backfilling” of Potting Compound 116 .
- the upper surface of each Annular Anchor 306 is that surface which faces outward toward the ends of Housing 102 .
- FIG. 4 shows a cross-section view of a portion of the single use dialyzer of FIGS. 1 and 2 in an embodiment of the present invention.
- Dialysate Compartment 402 and Blood Compartment 404 are the regions of ingress and egress of dialysate and blood through Dialysate Inlet/Outlet Ports 110 and Blood Inlet/Outlet Ports 118 respectively.
- Annular Inner Lip 410 and Annular Outer Lip 412 of Housing 102 receives Annular Tongue 316 in an interference based snap fit fashion. This connection is spin welded as described above.
- spin welding of polypropylene does not generally produce extensive spin welding particulate, but material does aggregate around the weld joint in the form of jagged flash (melted polymeric material) which aids in sealing welded parts together.
- Annular Channel 320 and Annular Channel 408 accommodate the flow of some of the melted flash material that is displaced during the spin welding process.
- Annular Interior Rim 414 and Annular Exterior Rim 416 form an annular groove for receiving Annular Outer Rim 312 of Ring 108 .
- This connection is spin welded as described above.
- Annular Channel 406 also accommodates the flow of some of the melted material that is displaced during the spin welding process.
- Annular Channel 422 is a specially designed area where Flange Cap 106 and Ring 108 seal off against each other during the spin welding process, entrapping additional amounts of melted flash material from the spin welding process. This design insures that no flash material is allowed to invade Blood Compartment 404 . Blood tends to coagulate on any rough surface exposed within Blood Compartment 404 , which would degrade the functioning of Filter Device 100 .
- Annular Channel 422 will also trap residue material from the other types of joining techniques mentioned above.
- the flat annular portions seal up against each other and ensure that the flash produced will not be introduced into the blood compartment of Filter Device 100 . However, the welding occurs only at the designated region and not at the flat annular regions where additional amounts of flash may be generated.
- Annular Outer Lip 412 extends up from Housing 102 along the exterior of Ring 108
- Annular Exterior Rim 416 extends down from Flange Cap 106 along the exterior of Ring 108 .
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Manufacturing & Machinery (AREA)
- External Artificial Organs (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Vacuum Packaging (AREA)
Abstract
A filter device made of less expensive material than comparable filter devices heretofore has basic filter components plus some unique design aspects and an additional ring component. The ring provides an interface inside the filter which enables the potting compound to adhere to the filter and create a seal between a first and second fluid compartment within the filter. An embedded region of the ring possesses a detailed geometry which helps ensure that a delamination would be localized and unable to propagate from the first to the second compartment, maintaining the structural integrity of the filter device. To ensure that the sealing interface remains intact and free from delamination, the ring is subjected to a surface treatment, which modifies the surface energy of the ring. This modified surface energy of the ring allows the hydrophilic potting compound to more effectively bond to the modified hydrophobic ring.
Description
- This application is a continuation of Application Ser. No. 10/007,516, filed on Dec. 5, 2001, titled “Filtering Device With Associated Sealing Design And Method”, now U.S. Pat. No. ______, which is incorporated herein by reference in its entirety.
- This invention relates to the field of filtering devices, and more particularly, to a hollow fiber type filter device having a single use or disposable design together with a method for using and manufacturing the same.
-
FIG. 1 shows an overall side view of an embodiment of the filter device of the present invention. -
FIG. 2 shows an exploded isometric view of the filter device ofFIG. 1 in an embodiment of the present invention. -
FIGS. 3A-3D show various views of the ring ofFIGS. 1 and 2 of an embodiment of the filter device of the present invention. -
FIG. 4 shows a cross-section view of a portion of the filter device ofFIG. 1 in an embodiment of the present invention. - Referring to the Figures, in which like numerals refer to like portions thereof,
FIG. 1 shows an overall side view andFIG. 2 shows an exploded isometric view of an embodiment of the filter device of the present invention. Referring now toFIGS. 1 and 2 ,Filter Device 100 in this embodiment of the invention is a dialyzer used for hemodialysis. One skilled in the art will recognize that the filter device of the present invention could also be used for filtering other types of fluids besides blood, including, but not limited to water, sewage, or other types of chemical separation. -
Filter Device 100 is a dialyzer utilized by patients with kidney disease who suffer from the adverse effects of toxin build-up in their blood. Dialysis is a process which employs an artificial kidney to remove those toxins. In hemodialysis a dialyzer is used which contains a semipermeable membrane dividing the dialyzer into two compartments. Blood is pumped through one compartment and a dialysate solution through the second. As the blood flows by the dialysis fluid, separated by the semipermeable membrane, blood impurities such as urea and creatinine diffuse through the semipermeable membrane into the dialysis solution by diffusion, convection, and absorption. The electrolyte concentration of the dialysis fluid is set so as to maintain electrolytic balance within the patient. - Dialyzers are known in a variety of configurations. The basic concept is to maximize the surface area of the membrane dividing the blood side from the dialysate side, so that the pressure gradient diffusing toxins from the blood side into the dialysate side and diffusing nutrients or pharmacological agents from the dialysate side into the blood side can operate over a wide area. On the other hand, there are size constraints to the overall three dimensional volume of the device, in order to fit into the hemodialysis apparatus.
-
Filter Device 100 has a large number of Microfibers 104 (not shown inFIG. 2 ) encased in aHousing 102, which is a hollow cylinder open at both ends. In other designs,Housing 102 may be open only at one end, and Microfibers 104 are looped in a U-shape inHousing 102 such that both open ends of each microfiber are located at the one open end of Housing 102 (not shown). In either design, thousands of the hollowsemipermeable Microfibers 104 carry blood in a pathway through one set of open ends of eachMicrofiber 104, through the interior of eachMicrofiber 104, and exiting out of the other open end of eachMicrofiber 104. - As shown in
FIG. 1 , thousands of the hollowsemipermeable Microfibers 104 carry blood in a pathway that enters from one end through a first Blood Inlet/Outlet Port 118 to the opposite end and out through a second Blood Inlet/Outlet Port 118 so that blood flows through the interior of eachMicrofiber 104 in a first direction. Dialysate Inlet/Outlet Ports 110 are also present on opposite ends ofHousing 102. A first Dialysate Inlet/Outlet Port 110 carries dialysate in a pathway intoHousing 102, the dialysate flows throughHousing 102 in a countercurrent direction to the blood flow and in the space between eachMicrofiber 104, and a second Dialysate Inlet/Outlet Port 110 carries the dialysate out ofHousing 102. The material exchange thus takes place across the semipermeable membrane that is the walls of eachMicrofiber 104.Label 114 is preprinted and applied after assembly. ACap 112 screws into each Blood Inlet/Outlet Port 118 after sterilization, and is utilized to ensure an uncontaminated fluid pathway and is typically not removed until the technician is ready to connect the blood lines. - The design of
Filter Device 100 produces a high surface area for material exchange in a relatively low volume device. For example, aFilter Device 100 having a 6.3 cm cylindrical diameter and a 25.4 cm length can easily accommodate a bundle of about 12,000 to 13,000Microfibers 104. If eachMicrofiber 104 has a 0.60 cm circumference and is 24 cm long, the total surface area of all 12,000-13,000Microfibers 104 is approximately 180 cm2. - The manufacture of
Filter Device 100 begins by joining Rings 108 into each end ofHousing 102. EachRing 108 is then joined toHousing 102. Many different joining techniques may be employed including, but not limited to, spin (friction) welding, laser welding, ultrasonic welding, high frequency welding, gluing, adhesive bonding, solvent bonding, screwing with threads, snap fitting, or any other suitable plastic joining technique. In this embodiment of the invention, spin welding is utilized. A plurality ofNubs 120 spaced apart on the outer surface ofRing 108 constitute the spin welding drive features to assist in the spin welding process. Next, open-ended Housing 102 is filled with a bundle of Microfibers 104 which extend in the longitudinal direction throughout the length ofHousing 102 and extending a short distance beyond each end. A Potting Cap 202 (FIG. 2 ) is attached to eachRing 108 to close off each end ofHousing 102.Housing 102 is then positioned in a centrifuge to allow rotation about an axis perpendicular to the central longitudinal axis, wherein the axis of rotation extends through the midpoint ofHousing 102. Potting Compound 116 is then injected into Dialysate Inlet/Outlet Ports 110 on each end ofHousing 102, is spun in a centrifuge, and the fibers are effectively potted in the dialyzer. Alternatively, each end ofHousing 102 may be separately spin welded and injected in a two step process. In one embodiment of the invention, polyurethane is used for Potting Compound 116. Epoxy or any other suitable compound may also be used as a potting material. The centrifugal force produced by the rotation in the centrifuge forces Potting Compound 116 to each end, where it sets and hardens. -
Housing 102 is then removed from the centrifuge, and eachPotting Cap 202 is removed from each end to expose the hardenedPotting Compound 116 encasing the ends of eachMicrofiber 104. Potting Compound 116 and the encasedMicrofibers 104 at each end are then cut through in a plane perpendicular to the central longitudinal axis ofHousing 102, and theMicrofibers 104 longitudinal axes, to expose the interior channels of eachMicrofiber 104. The result is that the ends of eachMicrofiber 104 are open for blood flow through the interior channels of eachMicrofiber 104 extending throughHousing 102, but the rest of the space surrounding eachMicrofiber 104 at both ends ofHousing 102 is filled with polyurethane, creating a seal between the blood and dialysate. - After the potting and cutting process, a
Flange Cap 106 is attached to eachRing 108 and spin welded together, permanently adhering it toFilter Device 100. This design eliminates an O-ring typically used to assist in the sealing of the blood compartment of a dialyzer. - Dialysate Inlet/
Outlet Port 110 in the walls ofHousing 102, which are toward but not at the very ends, remain open for dialysate flow there through. A dialysate line is connected to one Dialysate Inlet/Outlet Port 110 and a dialysate return line is connected to the other Dialysate Inlet/Outlet Port 110. The dialysate thus flows through the interior ofHousing 102 in the space surrounding theMicrofibers 104 in one direction. Blood flows from an arterial blood line from a patient connected to a first Blood Inlet/Outlet Port 118, entering the exposed ends of eachMicrofiber 104 and flowing through the interior channels through the length ofHousing 102 in a countercurrent direction, and then out of the other exposed ends of eachMicrofiber 104 and back to the patient through a venous blood line connected to a second Blood Inlet/Outlet Port 118. The blood is thus separated from the dialysate by the semipermeable membranes of the microfiber walls, which allow the transfer of liquids, toxins, and nutrients by solute diffusion and pressure gradients. - Typically, dialyzers are reused. After use in a hemodialysis session for a patient, the dialyzer is cleaned and sterilized for subsequent use by the same patient for a next hemodialysis session. The cleansing, sterilizing, storing, and cataloging of each dialyzer to ensure safe use by the same patient is an expensive and laborious task, and fraught with risk should the dialyzer not effectively have had all of the sterilizing chemicals removed from the dialyzer and the patient be exposed to the sterilizing agent itself. Additionally, if the sterilization process was not able to effectively sterilize the dialyzer, the patient may be subjected to a “non’ biocompatible medical device. Further logistic risk remain in the case the dialyzers get mixed up and the wrong dialyzer is used with the wrong patient. Heretofore, single use dialyzers have been too expensive to manufacture to be very practicable. To accommodate the growing demands of the hemodialysis market for single use or disposable dialyzers, the design of
Filter Device 100 of the present invention has solved the high cost problem associated with the current manufacture of disposable dialyzers, but yet maintain the performance and medical requirements necessary for successful hemodialysis. - Various seals in a dialyzer must remain intact, which is of special concern when replacing the currently proven expensive materials, from which many dialyzers are made, with less expensive materials in order to reduce costs. Any dialyzer inherently has at least two sealing regions in its respective design. First, the blood and dialysate compartments must be sealed from each other to ensure that a blood leak does not occur. The second seal consists of sealing either the blood or dialysate compartment from the exterior of the dialyzer.
- In nearly all dialyzers currently marketed throughout the world, polyurethane is used as a potting material to seal to the housing to ensure that the blood and dialysate compartments are sealed from each other. An O-ring is typically used to separate the blood from the exterior of the dialyzer.
- The seals in a dialyzer must not only maintain their integrity through a specified shelf life duration and during the dialysis treatment process, but must also maintain their integrity during the manufacturing process.
- The
Filter Device 100 of the present invention utilizes molded parts, includingHousing 102 andFlange Caps 106, made with a polypropylene homopolymer that possess comparable general characteristics to the polycarbonate used in the molded components of the Fresenius Hemoflow series of dialyzers, but is considerably less expensive. The choice of materials for the dialyzer are heavily dependent upon the manufacturing processes employed. Though the optical property of the polypropylene homopolymer is significantly more “hazy” compared to polycarbonate, the blood and dialysate compartments are still readily visible to technicians. - Polyurethane in one embodiment of the invention is used as
Potting Compound 116 forFilter Device 100. Instead of an O-ring, aseparate Ring 108 molded from polypropylene is utilized. OneRing 108 is spin welded into each end ofHousing 102.Flange Caps 106 are then spin welded ontoRings 108 afterFilter Device 100 has been potted and cut. Other joining techniques as listed above, including laser welding, may be used instead of spin welding. However, spin welding is based on a very simple concept and the process generally can be performed faster, less expensively, and with much less continuous maintenance and re-alignment as compared to laser welding. The weld joint designs utilized inFilter Device 100 are very robust and conducive to the rigors of large scale manufacturing. - During the potting process, the interior portion of each
Ring 108 becomes encased inPotting Compound 116. This creates the first seal between the blood and the dialysate compartments. After potting, the potting caps are removed, the ends are cut, andFlange Caps 106 are spin weld ontoRings 108. The spin welded region constitutes the second seal region, which seals the blood compartment from the outside of Filter Device 100 (a seal which has typically utilized an O-ring).Filter Device 100 is then conditioned during a low flux conditioning process, and then sterilized. Sterilization may be accomplished in a variety of ways, including ethylene oxide (EtO), steam, or radiation sterilization. - A disadvantage of polypropylene is that its hydrophobic property has a tendency to delaminate from the hydrophilic polyurethane potting material due to the chemistry of surface adhesion between the two materials, resulting in leaks between the blood and dialysate compartments. A two-pronged approach has been taken to solve this delamination problem associated with the use of polypropylene. The first involves building a detailed geometry into the design of
Ring 108 to minimize delamination or propagation of the delamination through the creation of physical stops, discussed more fully in relation toFIGS. 3A-3D . The second involves the modification of the surface characteristics of the polypropylene to increase adhesion between it and the polyurethane, also discussed more fully in relation toFIGS. 3A-3D . -
FIGS. 3A-3D show various views of an embodiment of the ring ofFIGS. 1 and 2 in an embodiment of the single use dialyzer of the present invention.FIG. 3A shows a front view ofRing 108.FIG. 3B shows a side view ofRing 108.FIG. 3C shows an isometric cross-sectional view of a portion ofRing 108 as seen along lines B-B ofFIG. 3A .FIG. 3D shows a cross-sectional view ofRing 108 as seen along line A-A ofFIG. 3A . - Referring now to
FIGS. 3A-3D ,Ring 108 is shaped to coincide withHousing 102 andFlange Caps 106 that eachRing 108 is mated with. Typically,Housing 102,Flange Caps 106, andRings 108 are circular, but other shapes may also be utilized.Ring 108 hasAnnular Tongue 316 which fits into an annular groove inHousing 102 formed byAnnular Inner Lip 410 andAnnular Outer Lip 412 in an interference based snap fit fashion in one embodiment of the invention (seeFIG. 4 ).Ring 108 also hasAnnular Outer Rim 312 andAnnular Inner Rim 314 which form an annular groove which is designed to receiveFlange Cap 106 in an interference based snap fit (seeFIG. 4 ).Potting Cap 202 used in the manufacturing process (FIG. 2 ) is also designed to fit into this annular groove. - Several methods are available to treat the surface of
Ring 108 to modify its surface energy to increase adhesion between it and the polyurethane, including plasma, corona discharge, and flame treatments. By increasing the ability of the surface ofRing 108 to adhere to the polyurethane,Ring 108 has been shown to be effective in eliminating potential issues regarding delamination. A delamination could potentially allow the two fluid pathways to mix outside of the filtering microfibers. The detailed geometry of the design ofRing 108 increases the surface area treatable through surface treatment, enhancing the effects of modifying the surface energy ofRing 108. - In one embodiment of the invention, a typical surface treatment process which allows for the most practical integration into a clean room automated assembly process is the “corona discharge” surface treatment technique. This treatment method is currently utilized in industry to increase the adhesion of inks, coatings, and adhesives to polyolefins, such as polypropylene. The corona discharge consists of a high voltage electrical discharge that is created between two electrodes across a specified distance. This discharge ionizes the gases present between the electrodes and creates unstable chemical species (mainly free radicals), which possess sufficient energy to initiate bond cleavage at the polymer surface. A small fan is situated just above the corona discharge heads and blows the reactive chemical species onto the polymeric surface of the part being treated,
Ring 108, as shown byarrows 308 inFIG. 3D .Ring 108 is especially well suited to accommodate the corona discharge treatment process, presenting a large surface area due to its geometric design. The corona discharge treatment process is based on the surface being treated to be directly exposed to the electrical discharge, and sections of the surface that are not directly in the “line of sight” of the discharge do not receive as effective treatment.Ring 108 is designed to ensure that the polyurethane interface regions of the ring receive optimal amounts of the surface treatment, while also forcing any delamination that may occur to follow a very difficult pathway. AnnularRounded Ridges 318 on the upper and lower surfaces ofAnnular Anchor 306 have relatively sharp transitions between them to ensure that optimal amounts of “treatable” area ofRing 108 are exposed to the corona discharge treatment process. When this entire section ofRing 108 is embedded in thePotting Compound 116, delamination is forced to essentially “start” again and again after being initiated anywhere along theRing 108/Potting Compound 116 interface as shown in a close up cross-section ofRing 108,Housing 102, andFlange Cap 106 shown inFIG. 4 . The effects of the corona discharge treatment may also be somewhat distributed onto AnnularRounded Ridges 318 in the lower surface ofAnnular Anchor 306 as the unreacted unstable chemical species will be blown into the center ofRing 108 and react with the lower surface ofRing 108, which also is embedded inPotting Compound 116. The thickness ofAnnular Anchor 306 tends to decrease or taper inwardly fromAnnular Outer Rim 312, as opposed to increasing or expanding inwardly, which aids in this surface treatment process. - Covalent bonds are produced on the surface of the polymer as the surface is oxidized during the treatment process. This oxidative coating on the polypropylene surface allows the hydrophilic polyurethane to effectively bond to the modified polypropylene. Because the oxidative coating on the polypropylene has the ability to interact with the oxygen present in the air, and simply the dynamic nature of polymers, the stability of the corona discharge treatment is limited to a specified amount of time. However, once potted, the modified surface of
Ring 108 is permanent and does not degrade over time. - A large portion of
Ring 108,Annular Anchor 306, serves as a mechanical lock and is located at an interior portion ofRing 108 and is completely embedded inPotting Compound 116. This portion ofRing 108 forces delamination to completely circumvent around and through the Annular RoundedRidges 318 to create an actual delamination between the blood and dialysate compartments ofFilter Device 100 as shown inFIG. 4 . - Another feature of
Ring 108 areRadial Channels 302. As the polyurethane potting mass “backfills” from the ends ofFilter Device 100, the residual air from the ends ofFilter Device 100 becomes entrapped due to AnnularRounded Ridges 318 ofAnnular Anchor 306 portion of the design ofRing 108. Not allowing the potting mass to bind to the corona discharge treated surface because of an air pocket could potentially create an initiation site for a delamination. To address this situation,Radial Channels 302 are periodically notched perpendicular to AnnularRounded Ridges 318 of the upper surface ofAnnular Anchor 306 ofRing 108, which allows the air to escape and not become trapped during “backfilling” ofPotting Compound 116. The upper surface of eachAnnular Anchor 306 is that surface which faces outward toward the ends ofHousing 102. -
FIG. 4 shows a cross-section view of a portion of the single use dialyzer ofFIGS. 1 and 2 in an embodiment of the present invention. Referring now toFIG. 4 ,Dialysate Compartment 402 andBlood Compartment 404 are the regions of ingress and egress of dialysate and blood through Dialysate Inlet/Outlet Ports 110 and Blood Inlet/Outlet Ports 118 respectively.Annular Inner Lip 410 andAnnular Outer Lip 412 ofHousing 102 receivesAnnular Tongue 316 in an interference based snap fit fashion. This connection is spin welded as described above. Typically spin welding of polypropylene does not generally produce extensive spin welding particulate, but material does aggregate around the weld joint in the form of jagged flash (melted polymeric material) which aids in sealing welded parts together.Annular Channel 320 andAnnular Channel 408 accommodate the flow of some of the melted flash material that is displaced during the spin welding process. - After the potting and cutting process, in similar fashion
Annular Interior Rim 414 andAnnular Exterior Rim 416 form an annular groove for receivingAnnular Outer Rim 312 ofRing 108. This connection is spin welded as described above.Annular Channel 406 also accommodates the flow of some of the melted material that is displaced during the spin welding process.Annular Channel 422 is a specially designed area whereFlange Cap 106 andRing 108 seal off against each other during the spin welding process, entrapping additional amounts of melted flash material from the spin welding process. This design insures that no flash material is allowed to invadeBlood Compartment 404. Blood tends to coagulate on any rough surface exposed withinBlood Compartment 404, which would degrade the functioning ofFilter Device 100. One skilled in the art will recognize thatAnnular Channel 422 will also trap residue material from the other types of joining techniques mentioned above. The flat annular portions seal up against each other and ensure that the flash produced will not be introduced into the blood compartment ofFilter Device 100. However, the welding occurs only at the designated region and not at the flat annular regions where additional amounts of flash may be generated. Additional regions that are designed to contain spin weld flash, or residue material from other types of joining techniques, are located around theHousing 102/Ring 108 weld interface asAnnular Outer Lip 412 extends up fromHousing 102 along the exterior ofRing 108, and around theFlange Cap 106/Ring 108 weld interface asAnnular Exterior Rim 416 extends down fromFlange Cap 106 along the exterior ofRing 108. These areas also minimize the flow of flash, or residue material from other types of joining techniques, outside ofFilter Device 100 improving the aesthetic features. - The results of various studies on
Filter Device 100 show that the design ofRing 108 provides an excellent surface for the corona discharge treatment prior to potting. Extensive quality and delamination testing from two separate experiments of nearly 600separate Filter Device 100 samples determined that the current design would have a 0.00% chance of delaminating with an upper binomial confidence level of 0.09%. Extensive testing shows that the design ofFilter Device 100 possesses excellent capability of resisting delamination, possesses high performance characteristics, and has significantly reduced manufacturing costs. In addition, the clearance characteristics ofFilter Device 100 are among the highest currently available on the market. - Having described the present invention, it will be understood by those skilled in the art that many and widely differing embodiments and applications of the invention will suggest themselves without departing from the scope of the present invention.
Claims (17)
1-61. (canceled)
62. A filter device comprising:
a housing having a first end;
a first ring joinable to said first end wherein said first ring has a first annular anchor on an interior portion of said first ring;
a first flange cap joinable to said first ring forming a first seal, wherein said first flange cap is separated from contact with said first end of said housing by said first ring;
a plurality of microfibers extending from said first ring through said housing; and
a first potting material encasing said plurality of microfibers at said first ring, encasing said first annular anchor, and contacting a portion of said first flange cap forming a second seal;
wherein said first seal prevents a first fluid introduced into the filter device from escaping to an exterior of the filter device, and said second seal prevents said first fluid from contacting a second fluid introduced into the filter device.
63. The filter device according to claim 62 further comprising:
a first plurality of rounded ridges on an upper surface of said first annular anchor and a second plurality of rounded ridges on a lower surface of said first annular anchor.
64. The filter device according to claim 63 further comprising:
a first plurality of radial channels perpendicular to said first plurality of rounded ridges on said upper surface of said first annular anchor;
wherein said first plurality of radial channels allow air to escape when said first potting material is applied to the filter device.
65. The filter device according to claim 63 wherein said first annular anchor receives a surface treatment, wherein said surface treatment modifies a surface energy of said first and second plurality of rounded ridges on said first annular anchor, and further wherein said first and second plurality of rounded ridges increases a surface area of said first annular anchor treatable through said surface treatment.
66. The filter device according to claim 62 further comprising:
a second end of said housing opposite said first end;
a second ring joinable to said second end wherein said second ring has a second annular anchor on an interior portion of said second ring;
a second flange cap joinable to said second ring forming a third seal, wherein said second flange cap is separated from contact with said second end of said housing by said second ring; and
a second potting material encasing said plurality of microfibers at said second ring, encasing said second annular anchor, and contacting a portion of said second flange cap forming a fourth seal;
wherein said third seal prevents said first fluid introduced into the filter device from escaping to said exterior of the filter device, and said fourth seal prevents said first fluid from contacting said second fluid introduced into the filter device.
67. The filter device according to claim 66 further comprising:
a third plurality of rounded ridges on an upper surface of said second annular anchor and a fourth plurality of rounded ridges on a lower surface of said second annular anchor.
68. The filter device according to claim 67 further comprising:
a second plurality of radial channels perpendicular to said third plurality of rounded ridges on said upper surface of said second annular anchor;
wherein said second plurality of radial channels allow air to escape when said second potting material is applied to the filter device.
69. The filter device according to claim 67 wherein said second annular anchor receives a surface treatment, wherein said surface treatment modifies a surface energy of said third and fourth plurality of rounded ridges on said second annular anchor, and further wherein said third and fourth plurality of rounded ridges increases a surface area of said second annular anchor treatable through said surface treatment.
70. The filter device according to claim 66 further comprising:
a first fluid inlet port through said first flange cap;
a first fluid outlet port through said second flange cap, wherein a first fluid pathway is defined by said first fluid inlet port, said plurality of microfibers, and said first fluid outlet port;
a second fluid inlet port through said housing and proximate to said first end; and
a second fluid outlet port through said housing and proximate to said second end, wherein a second fluid pathway is defined by said second fluid inlet port, a space between said plurality of microfibers, and said second fluid outlet port.
71. The filter device according to claim 66 wherein said first ring is spin welded to said first end, said second ring is spin welded to said second end, said first flange cap is spin welded to said first ring, and said second flange cap is spin welded to said second ring.
72. The filter device according to claim 71 further comprising:
a first plurality of nubs on an outer portion of said first ring; and
a second plurality of nubs on an outer portion of said second ring;
wherein said fist and second plurality of nubs assist in said spin welding.
73. The filter device according to claim 71 further comprising:
at least one annular channel located between said first ring and said first end; and
at least one annular channel located between said second ring and said second end;
wherein each of said at least one annular channel accommodates a flow of flash material during said spin welding.
74. The filter device according to claim 71 further comprising:
at least one annular channel located between said first ring and said first flange cap; and
at least one annular channel located between said second ring and said second flange cap;
wherein each of said at least one annular channel accommodates a flow of flash material during said spin welding.
75. The filter device according to claim 66 wherein said first ring is laser welded to said first end, said second ring is laser welded to said second end, said first flange cap is laser welded to said first ring, and said second flange cap is laser welded to said second ring.
76. The filter device according to claim 62 wherein each of said plurality of microfibers are hollow and semipermeable.
77. The filter device according to claim 62 wherein said housing is cylindrical in shape.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/982,451 US20050115885A1 (en) | 2001-12-05 | 2004-11-04 | Filtering device with associated sealing design and method |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/007,516 US6830685B2 (en) | 2001-12-05 | 2001-12-05 | Filtering device with associated sealing design and method |
| US10/982,451 US20050115885A1 (en) | 2001-12-05 | 2004-11-04 | Filtering device with associated sealing design and method |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/007,516 Continuation US6830685B2 (en) | 2001-12-05 | 2001-12-05 | Filtering device with associated sealing design and method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20050115885A1 true US20050115885A1 (en) | 2005-06-02 |
Family
ID=21726656
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/007,516 Expired - Lifetime US6830685B2 (en) | 2001-12-05 | 2001-12-05 | Filtering device with associated sealing design and method |
| US10/982,451 Abandoned US20050115885A1 (en) | 2001-12-05 | 2004-11-04 | Filtering device with associated sealing design and method |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10/007,516 Expired - Lifetime US6830685B2 (en) | 2001-12-05 | 2001-12-05 | Filtering device with associated sealing design and method |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US6830685B2 (en) |
| EP (1) | EP1323462B1 (en) |
| AT (1) | ATE503560T1 (en) |
| CA (1) | CA2412702A1 (en) |
| DE (1) | DE60239587D1 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102006021066A1 (en) * | 2006-05-05 | 2007-11-08 | Fresenius Medical Care Deutschland Gmbh | Method and device for introducing a potting compound into a filter device |
| WO2017088845A1 (en) | 2015-11-25 | 2017-06-01 | Serumwerk Bernburg Ag | Hollow fiber membrane filter device and method for producing same |
| EP3996893A1 (en) * | 2019-07-11 | 2022-05-18 | Xenios AG | Potting apparatus for a gas exchanger |
| WO2024234091A1 (en) * | 2023-05-15 | 2024-11-21 | Sadr Ghayeni Seyed B | Improved membrane bundle for vacuum membrane distillation and method for making same |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8414892B2 (en) * | 2000-10-18 | 2013-04-09 | Sloan-Kettering Institute For Cancer Research | Uses of monoclonal antibody 8H9 |
| EP1466657B1 (en) * | 2003-04-11 | 2012-10-03 | Gambro Lundia AB | Filter device having more than one filtration compartment |
| US7351332B2 (en) * | 2003-10-17 | 2008-04-01 | Varian, Inc. | Chromatography cartridge and method for manufacturing a chromatography cartridge |
| US20060249441A1 (en) * | 2005-05-04 | 2006-11-09 | Baur Jeffery W | Nanofluidic connector for hollow microfiber and method for manufacture thereof |
| DE102005043321A1 (en) * | 2005-09-12 | 2007-03-22 | Fresenius Medical Care Deutschland Gmbh | Hollow fiber membrane separation device |
| US20070251878A1 (en) * | 2006-05-01 | 2007-11-01 | Michael Saveliev | Low volume per output large in-line filter assembly |
| USD565728S1 (en) * | 2006-12-07 | 2008-04-01 | Fresenius Medical Care Holdings, Inc. | Universal dialyzer cap |
| USD579553S1 (en) * | 2007-09-19 | 2008-10-28 | Fresenius Medical Care Holdings, Inc. | Dialysis machine kit capture cassette |
| USD644730S1 (en) * | 2008-04-11 | 2011-09-06 | Gambro Lundia Ab | Module for fluid transport of medical fluid and blood |
| EP2181757A1 (en) * | 2008-10-30 | 2010-05-05 | Gambro Lundia AB | Leak testing of a pressure vessel |
| USD612513S1 (en) | 2009-07-29 | 2010-03-23 | Fresenius Medical Care Holdings, Inc. | Universal dialyzer cap |
| CN202740496U (en) | 2012-06-21 | 2013-02-20 | 甘布罗伦迪亚股份公司 | Capillary dialyzer |
| EP2735358B1 (en) * | 2012-11-22 | 2018-01-10 | Gambro Lundia AB | Capillary dialyzers |
| US20140263018A1 (en) * | 2013-03-15 | 2014-09-18 | Fresenius Medical Care Holdings, Inc. | Tether-retained dialyzer port cap and dialyzer including same |
| CA2914963C (en) * | 2013-06-12 | 2022-08-30 | Evonik Fibres Gmbh | Membrane cartridge system |
| JP6023013B2 (en) * | 2013-06-28 | 2016-11-09 | 株式会社キッツマイクロフィルター | Hollow fiber membrane module |
| CN103495217B (en) * | 2013-10-22 | 2016-03-16 | 威海威高血液净化制品有限公司 | A kind of hemodialyzer of polypropylene material shell and manufacture method thereof |
| DE102013112863A1 (en) * | 2013-11-21 | 2015-05-21 | Sartorius Stedim Biotech Gmbh | filter module |
| EP2878362B1 (en) * | 2013-12-02 | 2018-07-04 | Gambro Lundia AB | Capillary dialyzers |
| EP2883597A1 (en) | 2013-12-12 | 2015-06-17 | Gambro Lundia AB | Laser welding joint for dialyzer housings |
| JP6366025B2 (en) * | 2016-10-03 | 2018-08-01 | セルスペクト株式会社 | Plasma separator and plasma separation method |
| JP6242456B2 (en) * | 2016-10-06 | 2017-12-06 | 株式会社キッツマイクロフィルター | Hollow fiber membrane module |
| JP6835538B2 (en) * | 2016-11-08 | 2021-02-24 | ダイセン・メンブレン・システムズ株式会社 | A method of fixing at least one end of a hollow fiber membrane bundle to a tubular module case |
| JP6917153B2 (en) * | 2017-02-09 | 2021-08-11 | 株式会社クボタ | Membrane cartridge and membrane separator |
| EP3495033A1 (en) * | 2017-12-11 | 2019-06-12 | Gambro Lundia AB | Capillary dialyzer |
| CN109925553A (en) * | 2017-12-18 | 2019-06-25 | 光宝电子(广州)有限公司 | Haemodialyser and its manufacturing method |
| EP3765114B1 (en) | 2018-05-01 | 2021-08-25 | Fresenius Medical Care Holdings, Inc. | Multi-purpose cap for fluid ports on a medical device |
| DE102021132060A1 (en) | 2021-12-06 | 2023-06-07 | B.Braun Avitum Ag | filter module |
| CN115107285B (en) * | 2022-06-16 | 2024-04-02 | 乾德生物医疗技术(重庆)有限公司 | Method for manufacturing blood purification device |
| WO2025006750A2 (en) * | 2023-06-28 | 2025-01-02 | A.O. Smith Corporation | Filter and manufacturing apparatus and method for the same |
| CN116637509A (en) * | 2023-07-06 | 2023-08-25 | 广州康盛生物科技股份有限公司 | Hollow fiber membrane separator processing technology |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4157967A (en) * | 1976-03-25 | 1979-06-12 | Baxter Travenol Laboratories, Inc. | Blood filter |
| US4170056A (en) * | 1976-03-25 | 1979-10-09 | Baxter Travenol Laboratories, Inc. | Blood filter |
| US5182499A (en) * | 1990-10-25 | 1993-01-26 | Matsushita Electric Industrial Co., Ltd. | Sensorless brushless motor |
| US5236586A (en) * | 1991-08-01 | 1993-08-17 | Gambro Dialysatoren Gmbh & Co Kg | Apparatus for the treatment of fluids |
| US5472601A (en) * | 1993-04-20 | 1995-12-05 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Hollow fiber filter |
| US5632894A (en) * | 1994-06-24 | 1997-05-27 | Gish Biomedical, Inc. | Arterial blood filter with upwardly inclining delivery inlet conduit |
| US5922202A (en) * | 1996-01-11 | 1999-07-13 | Medtronic, Inc. | Inlet manifold for blood oxygenator apparatus |
| US6041559A (en) * | 1994-09-27 | 2000-03-28 | Huffy Corporation | Mounting structure for supporting a basketball pole |
| US6280619B1 (en) * | 1996-03-01 | 2001-08-28 | Sta-Rite Industries | Inline filter having swivel fitting |
| US6432307B2 (en) * | 1998-09-04 | 2002-08-13 | Ibs Filtran Kunstoff-/Metallerzeugnisse Gmbh Industriestr Spx Corporation-Filtran | Transmission filter with laser welded housing components |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3377973D1 (en) * | 1982-12-20 | 1988-10-20 | Baxter Travenol Lab | End closure for tubular housing |
| JPS645564A (en) | 1987-06-29 | 1989-01-10 | Terumo Corp | Heat or mass exchange apparatus |
| JPH0347271A (en) | 1989-07-14 | 1991-02-28 | Terumo Corp | Liquid treatment device |
| EP0922476A3 (en) | 1991-06-28 | 1999-07-07 | Pall Corporation | Filter assembly with a spin welded end cap |
| JPH08229359A (en) * | 1995-02-28 | 1996-09-10 | Kanegafuchi Chem Ind Co Ltd | Production of hollow-fiber membrane-type filter module |
| EP0844015B1 (en) | 1996-11-21 | 2003-10-15 | Fresenius Medical Care Deutschland GmbH | Hollow fiber membrane separation device |
| JPH10165777A (en) * | 1996-12-13 | 1998-06-23 | Toray Ind Inc | Hollow yarn module and its production |
| SE523122C2 (en) * | 1999-03-05 | 2004-03-30 | Gambro Dialysatoren | Filters with hollow fiber membrane |
| US7014765B2 (en) * | 2000-02-17 | 2006-03-21 | Gambro Dialysatoren Gmbh & Co. Kg | Filter comprising membranes made of hollow fibers |
-
2001
- 2001-12-05 US US10/007,516 patent/US6830685B2/en not_active Expired - Lifetime
-
2002
- 2002-10-28 CA CA002412702A patent/CA2412702A1/en not_active Abandoned
- 2002-12-03 AT AT02258317T patent/ATE503560T1/en not_active IP Right Cessation
- 2002-12-03 DE DE60239587T patent/DE60239587D1/en not_active Expired - Lifetime
- 2002-12-03 EP EP02258317A patent/EP1323462B1/en not_active Expired - Lifetime
-
2004
- 2004-11-04 US US10/982,451 patent/US20050115885A1/en not_active Abandoned
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4157967A (en) * | 1976-03-25 | 1979-06-12 | Baxter Travenol Laboratories, Inc. | Blood filter |
| US4170056A (en) * | 1976-03-25 | 1979-10-09 | Baxter Travenol Laboratories, Inc. | Blood filter |
| US5182499A (en) * | 1990-10-25 | 1993-01-26 | Matsushita Electric Industrial Co., Ltd. | Sensorless brushless motor |
| US5236586A (en) * | 1991-08-01 | 1993-08-17 | Gambro Dialysatoren Gmbh & Co Kg | Apparatus for the treatment of fluids |
| US5472601A (en) * | 1993-04-20 | 1995-12-05 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Hollow fiber filter |
| US5632894A (en) * | 1994-06-24 | 1997-05-27 | Gish Biomedical, Inc. | Arterial blood filter with upwardly inclining delivery inlet conduit |
| US6041559A (en) * | 1994-09-27 | 2000-03-28 | Huffy Corporation | Mounting structure for supporting a basketball pole |
| US5922202A (en) * | 1996-01-11 | 1999-07-13 | Medtronic, Inc. | Inlet manifold for blood oxygenator apparatus |
| US6280619B1 (en) * | 1996-03-01 | 2001-08-28 | Sta-Rite Industries | Inline filter having swivel fitting |
| US6432307B2 (en) * | 1998-09-04 | 2002-08-13 | Ibs Filtran Kunstoff-/Metallerzeugnisse Gmbh Industriestr Spx Corporation-Filtran | Transmission filter with laser welded housing components |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102006021066A1 (en) * | 2006-05-05 | 2007-11-08 | Fresenius Medical Care Deutschland Gmbh | Method and device for introducing a potting compound into a filter device |
| DE102006021066B4 (en) * | 2006-05-05 | 2009-06-25 | Fresenius Medical Care Deutschland Gmbh | Method and device for introducing a potting compound into a filter device |
| US20090238967A1 (en) * | 2006-05-05 | 2009-09-24 | Markus Helff | Process and Apparatus for Introducing a Potting Composition Into a Filter Apparatus |
| US8215261B2 (en) | 2006-05-05 | 2012-07-10 | Fresenius Medical Care Deutschland Gmbh | Process and apparatus for introducing a potting composition into a filter apparatus |
| WO2017088845A1 (en) | 2015-11-25 | 2017-06-01 | Serumwerk Bernburg Ag | Hollow fiber membrane filter device and method for producing same |
| EP3996893A1 (en) * | 2019-07-11 | 2022-05-18 | Xenios AG | Potting apparatus for a gas exchanger |
| WO2024234091A1 (en) * | 2023-05-15 | 2024-11-21 | Sadr Ghayeni Seyed B | Improved membrane bundle for vacuum membrane distillation and method for making same |
Also Published As
| Publication number | Publication date |
|---|---|
| DE60239587D1 (en) | 2011-05-12 |
| EP1323462A2 (en) | 2003-07-02 |
| CA2412702A1 (en) | 2003-06-05 |
| US20030102264A1 (en) | 2003-06-05 |
| EP1323462B1 (en) | 2011-03-30 |
| ATE503560T1 (en) | 2011-04-15 |
| EP1323462A3 (en) | 2005-01-19 |
| US6830685B2 (en) | 2004-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6830685B2 (en) | Filtering device with associated sealing design and method | |
| EP3765114B1 (en) | Multi-purpose cap for fluid ports on a medical device | |
| US7776219B2 (en) | Methods, devices, and systems for hemodilution | |
| JP2887347B2 (en) | Diffusion / filtration apparatus and method for manufacturing the same | |
| US6426002B1 (en) | Filter device | |
| US7297270B2 (en) | Hollow fiber filter for extracorporeal blood circuit | |
| EP0408000A1 (en) | Fluid processing apparatus | |
| JPH09122230A (en) | Reusable blood line | |
| GB1602060A (en) | Artificial kidney and method for making same | |
| CA2338952A1 (en) | Method for efficient hemodiafiltration | |
| JP2007301379A (en) | Multiple processing chamber set and use thereof | |
| KR20170117564A (en) | Hollow Sterilized Blood Purifier | |
| US20090050556A1 (en) | Filter device | |
| JP2009240499A (en) | Hemodiafiltration module | |
| JP2000042100A (en) | Hollow fiber membrane type liquid treatment apparatus | |
| US12311318B2 (en) | Potting process and apparatus | |
| CN221084313U (en) | Dialyser | |
| EP4065189B1 (en) | Pressure relief mechanism for sorbent canisters | |
| JP2008093518A (en) | Hemodiafiltration module | |
| JP2005230222A (en) | Manufacturing method of body fluid treatment device of hollow fiber membrane type, and body fluid treatment device of hollow fiber membrane | |
| JPH11532A (en) | Hollow yarn module and its production |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: FRESENIUS USA, INC., MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:POPE, RODNEY WILLIAM;STROUP, ERIC WILSON;BROWN, WILLIAM KELLY;AND OTHERS;REEL/FRAME:017350/0465;SIGNING DATES FROM 20011129 TO 20011130 |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |